Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs - sprookjes - yvandenbroek - TriplyDB

Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs

Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs

http://www.wikidata.org/entity/Q34911093

about

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples Influence of stochastic gene expression on the cell survival rheostat after traumatic brain injury Multifunctional antioxidants for the treatment of age-related diseases Cell death Advances in iron chelation: an update.Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma.DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.Neurite Outgrowth and Neuroprotective Effects of Quercetin from Caesalpinia mimosoides Lamk. on Cultured P19-Derived Neurons Phenotypic assays for β-amyloid in mouse embryonic stem cell-derived neurons Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Treatment strategies for Parkinson's disease.Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond.A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy.Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease.

P2860

Q24289511-D4398576-C5E0-41EF-8765-B9B03444A852 Q28476525-DB6E3FA8-AEBD-4A09-8DFA-594D01E9DF17 Q33524505-207D1B44-B4C9-4FF9-86DE-0E8772A915DB Q34019760-79EF52F6-B619-4B29-B17A-E7987F69C04D Q34174307-CD3DFE45-61CC-4465-983D-8543DE4FB557 Q35157723-57482C84-E6A0-44F5-B72E-1B51838A55FF Q36010298-BB5EFB72-E269-4251-94FD-14A448E1EA36 Q36956015-216C907F-2A26-4226-924E-50A30FA36774 Q37191636-99AEA2BE-6DAA-491C-9778-65D191218166 Q37418049-2604F45A-BBEA-4E32-9E6D-856B9E45E49C Q37559812-0DEA1356-FED7-4B15-A229-6172EF2B6770 Q37681312-19715F98-C785-4717-AF82-38599C593025 Q37981634-0EE3F81A-6B9F-45DD-82C6-F6C1A8E76684 Q38447289-BEB7D938-E181-44A0-A112-ACC0A92F293B Q44286743-27A33CE7-5A46-466D-9822-7ECF8375ABA9 Q52574481-C8D7D492-C214-451C-93DB-E9AF6CAE93F8

P2860

Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs

http://www.wikidata.org/entity/Q34911093

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@ast

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@en

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@nl

type

label

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@ast

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@en

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@nl

altLabel

Multifunctional neuroprotectiv ...... anti-alzheimer’s disease drugs

@en

prefLabel

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@ast

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@en

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@nl

P1433

Q34911093-02597000-E655-4BE9-B719-3B814C7FF8F2

P1476

Q34911093-CF6989BE-8585-4CB9-AA81-A39656C749D5

P2093

Q34911093-15122F1B-7A6A-48C4-A9F8-B926703EDE2B

Q34911093-1A097FE9-69C5-462F-A0BC-044F8C525907

Q34911093-1B961E00-3432-478A-BA90-6948B01D641F

Q34911093-6E534C8D-2461-45C6-94F8-050591AED858

Q34911093-94BAC716-5F78-48B7-9B8F-43C9D271F67F

Q34911093-BA168C01-D0E4-4E94-A1D6-489B5DD08095

Q34911093-F7F9E072-9513-4AC6-A4DF-68223FBE4932

P2860

Q34911093-00377271-FE64-4772-AC0C-535355722FE3

Q34911093-071B6EC7-6857-42D0-BD6C-4628D72BDC19

Q34911093-071C4470-8204-4145-AFAC-A3CCF7A92BCD

Q34911093-0891CDE1-BF84-41CB-AEA8-B68F220601C2

Q34911093-109F59E4-481A-49E3-A361-4824149C838A

Q34911093-117D6438-A2A1-4E78-AC1B-848691B23385

Q34911093-12D3BE52-C12B-4FDE-BFE8-BFD0785E5DE5

Q34911093-14F5EA83-77F3-457B-9CF7-965707062FC0

Q34911093-19AAEA01-2D07-41DF-84A2-EFB12D0D93B7

Q34911093-1E964DC1-2EB6-4F58-A835-73775BB5C134

P2888

Q34911093-8AA391E7-70BF-43ED-AFF1-176F7C127FD6

P304

Q34911093-F54A6090-F689-4FBA-93C2-93B4B5AE09D6

P31

Q34911093-DD91576D-BC52-4D89-8F85-4B259E60C5CA

P356

Q34911093-9670B571-6E8D-4492-9D90-DFD98D465D7F

P433

Q34911093-68F9034E-908D-4F4A-B37A-3DCAB2A092A0

P478

Q34911093-287ABEC3-A10A-4DB0-AEA3-556F4E589E32

P577

Q34911093-1AFC3C1D-A3F9-45A6-91F5-53ABAA74987C

P5875

Q34911093-E8B4DA96-791E-4F42-887C-6105F5C353BC

P6179

Q34911093-DC0A53D1-F1E3-4D29-9D85-F7AAF7602FDB

P698

Q34911093-B233E0E2-948E-47E1-97D8-23B47E7F46D0

P921

Q34911093-6694BA34-6703-4D01-A2E8-A7C641FA77ED

P932

Q34911093-61A3C03F-4D15-4568-AD49-6B3366FD2590

P356

J.NURT.2008.10.030

P1433

Neurotherapeutics

P1476

Multifunctional neuroprotectiv ...... anti-Alzheimer's disease drugs

@en

P2093

Merav Yogev-Falach

http://www.w3.org/2001/XMLSchema#string

Moussa B H Youdim

http://www.w3.org/2001/XMLSchema#string

Orit Bar-Am

http://www.w3.org/2001/XMLSchema#string

Orly Weinreb

http://www.w3.org/2001/XMLSchema#string

Silvia Mandel

http://www.w3.org/2001/XMLSchema#string

Tamar Amit

http://www.w3.org/2001/XMLSchema#string

Yael Avramovich-Tirosh

http://www.w3.org/2001/XMLSchema#string

P2860

The cholinergic hypothesis of Alzheimer's disease: a review of progress

Therapeutic approaches to Alzheimer's disease

Role of acetylcholinesterase inhibitors in the metabolism of amyloid precursor protein

Neuronal apoptosis: BH3-only proteins the real killers?

Can we rationally design promiscuous drugs?

Presence and induction of the enzyme NAD(P)H: quinone oxidoreductase 1 in the central nervous system

The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity

Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro.

The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells.

The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

P2888

j.nurt.2008.10.030

P304

163-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NURT.2008.10.030

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23706882

http://www.w3.org/2001/XMLSchema#string

P6179

1001836577

http://www.w3.org/2001/XMLSchema#string

P698

19110207

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5084264

http://www.w3.org/2001/XMLSchema#string